Here’s why we should be paying special attention to women's depression treatment.
Mark Heinemeyer
Advertisement
Mark Heinemeyer is CEO of PRODEO.
Articles by Mark Heinemeyer
Brain Capital: An Emerging Investment Opportunity
ByHarris A. Eyre, MD, PhD,Mark Faulkenberg,Sanjiv Das,James T. Hackett,Shuo Chen, JD,Francois Véron,Pawel Swieboda,Geoffrey S.F. Ling, MD, PhD,Eric W. Bennett,Shekhar Saxena, MD,Steve Carnevale,Ethan Powell,Erin Smith,Agustin Ibañez, PhD,Stephen T. Wong, PhD,Eric A. Storch, PhD,Evelyn Chan, MBBS, MSc,Mark Heinemeyer,Ian Robertson, PhD,Walter D. Dawson, DPhil,Dapo Tomori, MD,Jair C. Soares, MD,Ryan Abbott, MD, JD, PhD,Sebastian F. Winter, MD,Sandra Bond Chapman, PhD,Anastasia Budinskaya, MSc,Lisa Brown, PhD,Lynne Corner, PhD,Kirk Nylen, PhD,Garth Smith, PhD,Tom Mikkelsen, MD,Michael Berk, MD, PhD
Brain Capital: a fresh approach to technologies and investing.
Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype Cycle
ByHenry Asher,Erin Smith,Mark Heinemeyer,Michael Berk, MD, PhD,Agustin Ibañez, PhD,Shuo Chen, JD,Ernestine Fu, PhD,Jessica Wolfe, PhD, MPH,Ryan Abbott, MD, JD, PhD,Francois Véron,William Ellsworth,Marion Leboyer, MD, PhD,Geoffrey S.F. Ling, MD, PhD,Igor Linkov, PhD, MSc,Magali Haas, MD, PhD,Harris A. Eyre, MD, PhD
New approaches to ensure that the brain health technology sector continues to flourish for decades.
Information asymmetry occurs when one party has more or better information than the other party. Asymmetry and fraud will sour investor interest in the field.
The key to addressing mental health may lie in business innovation theories.
Boosting Brain Health After COVID-19: A Convergence Solution
ByHarris A. Eyre, MD, PhD,Jessica Carson,Erin Smith,Helen Lavretsky, MD, MS,Charles F. Reynolds III, MD,Husseini K. Manji, MD,Walter D. Dawson, DPhil,Laura Booi, PhD,Mark Heinemeyer,Jeffrey L. Cummings, MD, ScD,Ernestine Fu, PhD,Eric A. Storch, PhD,William Hynes, DPhil,Eric J. Lenze, MD,Retsina Meyer, PhD,Ian Macrae, PhD,Antonella Santuccione Chadha, MD,Ryan Abbott, MD, JD, PhD,Sandra Bond Chapman, PhD,Ian Robertson, PhD,Carol Graham,Brisa S. Fernandes, MD, MSc, PhD,David G. Angeler, PhD,Adrienne Grzenda, MD, PhD,Agustin Ibañez, PhD,Zoltan Sarnyai, MD, PhD,Sofia Marcha,Michael Berk, MD, PhD,Patrick Brannelly
How can we face the current pandemic while addressing the brain health crisis?
What consequences will big data and artificial intelligence have on brain health and economics?
Advertisement
Latest Updated Articles
Boosting Brain Health After COVID-19: A Convergence SolutionPublished: May 14th 2021 | Updated:
Move Over Data, Brain Capital is the New OilPublished: January 14th 2021 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
2
Preliminary Report on Dangers of AI Chatbots
3
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
